Participant was \>20 years and \<75 years of age on the index date (i.e., the date of initiating MK-0954A therapy)

Diagnosed with hypertension and had received MK-0954A 50/12.5 mg for at least 3 months

Had at least one serum uric acid measurements at baseline and one at 3 months after using MK-0954A 50/12.5 mg

Had the following records documented in the chart during the data collection period:

* medical history and co-morbidities (if available)

* sitting blood pressure, serum uric acid, lipid profile test results before and after using MK-0954A 50/12.5 mg

* serum electrolytes, serum creatinine, and pre-meal sugar (if available)

* prescription information of all antihypertensive regimens

Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)